Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|May 1, 2016

BioPharm International

  • BioPharm International-05-01-2016
  • Volume 29
  • Issue 5

Ultracentrifuge Allows for Multi-Wavelength Analysis

Listen
0:00 / 0:00

Key Takeaways

  • The Optima AUC ultracentrifuge determines molecular weight, size, shape, and polydispersity with advanced features for comprehensive analysis.
  • A 15-inch touch-screen and remote data export capabilities enhance user interaction and data management.
SHOW MORE

The Optima AUC from Beckman Coulter Life Sciences is an ultracentrifuge that determines molecular weight, size shape, and polydispersity.

The Optima AUC from Beckman Coulter Life Sciences is an ultracentrifuge that determines molecular weight, size shape, and polydispersity. The Optima AUC has a 38.1-cm (15-inch diagonal) touch-screen with the ability to export data locally or remotely. The optics are contained outside the rotor chamber, reducing the impact of the g-force on the optics. The Optima AUC also allows molecules to float free and unbound so that researchers are able to characterize them in their native state. The ultracentrifuge can perform multi-wavelength analysis and allows for the development of new detection systems.

Beckman Coulter Life Sciences
 


Related to this article

The BioPharm Brief: FDA’s Fast-Track Pilot Reportedly Stalls, a Long-Acting Bispecific for Atopic Dermatitis, and a Twice-Yearly Obesity Approach
FDA has reportedly shelved its Commissioner’s National Priority Voucher pilot and paused publishing complete response letters, Zai Lab’s IL-13/IL-31Rα bispecific ZL-1503 shows a 40- to 50-day half-life that points to dosing every 12 weeks, and Wave Life Sciences reports 1-year INLIGHT data for its INHBE-silencing siRNA WVE-007 in obesity.